Season 1, Episode 1
Smart KPIs for Biotechs
Sabine Hutchison and Alan Morgan discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Listen to the full episode right now!
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Alan Morgan is an experienced leader in pharmaceutical services, having operated in C suite roles for 25 years. He is an advisor and consultant within Private Equity, a non-executive advisor to Excelya in Paris, non-executive chairman of Gentronix Limited (a genetic toxicology early stage CRO PE backed), and an advisor to Luure.ai , a US based AI tech startup.
Join the discussion and listen to the full episode here.
Related Episodes
S2 E4 – AI in Biotech: Hype, Reality, and the Future of Drug Development
Season 2, Episode 4 AI in Biotech: Hype, Reality, and the Future of Drug DevelopmentIn the fourth episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the very insightful AI thought leader Christina Busmalis. Their conversation, titled...
S2 E3 – Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
Season 2, Episode 3 Transforming Clinical Trials: How Digital Endpoints Are Leading the WayIn the third episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by Victoria Bangieva from the Digital Medicine Society (DiMe) and our very own...
Key takeaways
- Sabine Hutchison and Alan Morgan discuss measuring what truly matters in clinical trials.
- Most trial KPIs measure activity rather than progress, which is why dashboards can look healthy while a trial drifts.
- Smart KPIs are the ones that would change a decision if they moved.
Frequently asked questions
Measures tied to what actually matters for the trial's outcome, rather than counts of activity that are easy to collect and tell you little.
Sabine Hutchison, Seuss+ CEO and co-founder, in conversation with Alan Morgan.
Because they measure what is easy to count. If a KPI would not change a decision when it moves, it is reporting, not measurement.
Stay Connected to Get The Latest Podcast Alerts
CUT THE CHAT - LIFE SCIENCE INSIDER
Listen Now!
An informative podcast series designed quite literally to cut the unnecessary talk and get straight to the point and heart of many life science and biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
0 Comments